Afsaneh lavasanifar google scholar
WebNov 23, 2024 · Delivery of chemotherapeutics to cancer cells using polymeric micelles is a promising strategy for cancer treatment. However, limited stability of micelles, premature drug release and off-target effect are the major obstacles that restrict the utilization of polymeric micelles as effective drug delivery systems. In this work, we addressed these … WebAfsaneh Lavasanifar: Nano-delivery of Novel Inhibitors of DNA Repair for Enhanced Cancer Therapy: Making a case for the use of nano-medicine in the drug development process 29 June 2024 NMIN Lecture Warren Chan: The nanoparticle biological identity & protein corona: Challenges, opportunities, & future research directions
Afsaneh lavasanifar google scholar
Did you know?
WebAfsaneh Lavasanifar’s Post Afsaneh Lavasanifar Professor at the University of Alberta 1y WebApr 28, 2024 · Afsaneh Lavasanifar is a professor in the University of Alberta’s Faculty of Pharmacy & Pharmaceutical Sciences and an adjunct professor in the Department of …
WebOmmoleila Molavi 1 , Zengshuan Ma, Samar Hamdy, Afsaneh Lavasanifar, John Samuel. Affiliation 1 Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada. PMID: 18798092 DOI: 10.1080/08923970802380452 Abstract The efficiency of cancer immunotherapy strategies is hampered by the existence of an … WebAfsaneh Lavasanifar - Professor - University of Alberta LinkedIn Afsaneh Lavasanifar Professor at the University of Alberta Edmonton, Alberta, Canada 3K followers 500+ …
WebJun 30, 2024 · In this NMIN lecture, delivered 29 June 2024, Dr. Afsaneh Lavasanifar discusses the efforts in her lab to harness the benefits of nanomedicine in the drug development process … WebSep 28, 2015 · Afsaneh Lavasanifar Pharmaceutical Research 33 , 358–366 ( 2016) Cite this article 925 Accesses 16 Citations Metrics Abstract Purpose To assess the potential of triblock copolymers based on poly (ethylene glycol) (PEG) and functionalized poly (ε-caprolactone) as temperature/pH responsive gels for controlled delivery of …
WebDr. Afsaneh Lavasanifar is expert in pharmaceutics and drug delivery. She is a professor in the Pharmaceutical Sciences division of the Faculty of Pharmacy and Pharmaceutical …
WebAfsaneh Lavasanifar Inhibition of the DNA repair enzyme polynucleotide kinase/phosphatase (PNKP) increases the sensitivity of cancer cells to DNA damage by ionizing radiation (IR). We have... calwinweb.orgWeb[Google Scholar] [Green Version] ... Kamaljit Kaur, Francesco Cuda, Ali Tavassoli, and Afsaneh Lavasanifar. 2024. "Modulation of Hypoxia-Induced Chemoresistance to Polymeric Micellar Cisplatin: The Effect of Ligand Modification of Micellar Carrier Versus Inhibition of the Mediators of Drug Resistance" Pharmaceutics 10, ... calwin ventura countyWebAug 18, 2024 · Zeinab Mahboobi, 1 Afsaneh Pakdaman, 2 , 1 , * Reza Yazdani, 1 Leila Azadbakht, 3 and Ali Montazeri 4 Author information Article notes ... [Google Scholar] 11. Ollila P, Larmas M. A seven-year survival analysis of caries onset in primary second molars and permanent first molars in different caries risk groups determined at age two years. ... calwin trainWebSarthak Patel 1 , Afsaneh Lavasanifar, Phillip Choi. Affiliation 1 Department of Chemical and Materials Engineering, University of Alberta, Edmonton, Alberta, Canada. PMID: 18937398 DOI: 10.1021/bm800320z Abstract In the present work, molecular dynamics (MD) simulation was applied to study the solubility of two water-insoluble drugs ... coffee analyzerWebKing's Prize Fellow job with King's College London at Guy's/St Thomas/Denmark Hill/Strand Campus calwin tracetoolWebDr. Lavasanifar has more than 160 peer reviewed manuscripts in highly ranked journals in pharmaceutical sciences, 3 book chapters, several abstracts, numerous conference presentations and invited talks in national and international conferences. She is the main inventor or co-inventor in 12 different issued or pending patent applications. calwin vs calworksWebDec 1, 2010 · The development of antisense oligonucleotides suitable for tumor targeting applications is hindered by low stability and bioavailability of oligonucleotides in vivo and by the absence of efficient and safe vectors for oligonucleotide delivery. Whereas stabilization in vivo has been achieved through chemical modification of oligonucleotides by various … calwin workflow